Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Email this article to a friend

Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial

Vibeke Strand email, Philip Mease email, Gerd R Burmester email, Enkeleida Nikaï email, Geoffroy Coteur email, Ronald van Vollenhoven email, Bernard Combe email, Edward C Keystone email and Arthur Kavanaugh email

Arthritis Research & Therapy 2009, 11:R170doi:10.1186/ar2859

Your name*
Your email address*
Recipient's email address*
(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:

© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.